Fuda Cancer Hospital
Stomach cancer treatment cost in China runs from $100 to $600 for a gastroscopy. Major procedures like stomach cancer surgery costs $18,500 to $34,500, while chemotherapy for stomach cancer ranges from Price on request to Price on request . Total expenses depend on the cancer stage, hospital tier, and surgical approach. International patients typically see 80-85% savings compared to the US. Top cities for oncology include Guangzhou, Shanghai, and Beijing.
Typical Stomach Cancer Treatment Costs in China
Bookimed Expert Insight: Advanced-stage patients often benefit from integrated, non-traditional protocols. Fuda Cancer Hospital specializes in late-stage care using NanoKnife and cryosurgery. This JCI-accredited facility has served 30,000 international patients. For those needing precision radiation, Dr. Liu Shi Xin at Xiamen Humanity Hospital offers expert-led radiotherapy. Choosing specialized oncology hubs provides better value for complex, multidisciplinary cases than general hospitals.
| China | Turkey | Austria | |
| Stomach resection | from $18,500 | from $12,000 | from $22,000 |
| Stomach cancer surgery | from $18,500 | from $12,000 | from $30,000 |
| Radiation therapy for stomach cancer | from $8,500 | from $3,250 | from $6,868 |
| Proton-beam therapy | from $36,500 | from $70,000 | from $80,000 |
| NanoKnife | from $22,500 | from $9,500 | from $25,000 |
Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.
Professor Liang Xiaoxiao is the Department Director and Chief Physician in Neurorehabilitation. She holds a master’s degree in neurology. She is skilled in neuromodulation for disorders of consciousness, cognition, and movement. Her focus includes cases from cerebrovascular disease, Parkinson’s disease, and related conditions. She also performs ultrasound-guided botulinum toxin injections for blepharospasm, hemifacial spasm, limb spasticity, sialorrhea, and neuralgia.
Accreditations and roles: Member of the Neurorehabilitation, Cognitive Disorder Rehabilitation, and Craniocerebral Trauma Rehabilitation Committees of the Chinese Association of Rehabilitation Medicine. Standing Member of the Cognitive Disorder Rehabilitation Committee of the Fujian Association of Rehabilitation Medicine. Vice Chair of the Dementia and Cognitive Disorder Committee of the Xiamen Preventive Medicine Association. Vice President of the Parkinson’s Disease and Movement Disorders Committee of the Xiamen Medical Doctor Association. Standing Member of the Neuromodulation Committee of the Xiamen Medical Doctor Association. Recipient of the Most Beautiful Physician of Xiamen City (2024).
Professor Zheng Qiu Hong is Director of the Cell Therapy Research Center and a National Senior Expert in Biotherapy. He is a Professor and Master’s Supervisor at Fujian Medical University. He has more than 30 years of clinical experience in tumor molecular biology and biotherapy. From 2012 to 2013, he was a visiting scholar in stem cell research at the University of Connecticut School of Life Sciences. He previously held leadership roles at Fujian Cancer Hospital. These roles included Director of the Tumor Molecular Biology Laboratory and Director of the Surgical Oncology Research Laboratory. He also served as Deputy Director of the Fujian Key Laboratory of Tumor Biotherapy and Deputy Director of the Biotherapy and Immunotherapy Center.
Appointments include Standing Committee Member of the Biotherapy Committee of the Chinese Research Hospital Association. He is also a Committee Member of the Tumor Immunology and Biotherapy Committee of the Chinese Society for Immunology. In addition, he is Deputy Chair of the Academic Committee of the Xiamen Cell Therapy Research Center at the First Affiliated Hospital of Xiamen University.
Dr. Leng Yin specializes in treating cancers of the liver, gallbladder, stomach, pancreas, and intestines at Fuda Cancer Hospital.
Chinese oncologists at top-tier facilities follow national certification standards that align with international benchmarks. Leading surgeons often hold Chief Physician titles and practice in JCI-accredited hospitals. These specialists frequently maintain memberships in global bodies like the Chinese Anti-Cancer Association while following internationally recognized CSCO treatment guidelines.
Bookimed Expert Insight: Case volume in China often translates to higher technical proficiency for stomach cancer. Specialists at flagship hospitals may perform 1,000+ gastrectomies annually. This volume far exceeds most Western counterparts. When selecting a surgeon, prioritize those at JCI-accredited facilities in Guangzhou or Shanghai. These doctors frequently hold dual training from Western or Japanese institutions, ensuring they meet rigorous international surgical protocols.
Patient Consensus: Patients emphasize choosing surgeons at Tier-1 hospitals in major cities for the best results. They note that top doctors often speak English well and have extensive experience with robotic or laparoscopic techniques.
The 5-year survival rate for stomach cancer in China ranges from 35.1% to 46.1% nationwide. Specialized cancer centers report surgical survival rates reaching 69.8%. Early-stage diagnosis (Stage I) offers the best prognosis. Survival for these patients often reaches 85% to 95%.
Bookimed Expert Insight: Clinical data shows a major distinction between general hospitals and high-volume specialty centers in Guangzhou. Fuda Cancer Hospital has treated over 30,000 international patients. It focuses on minimally invasive therapies like NanoKnife. Choosing centers that prioritize these technologies over standard chemotherapy often improves quality of life during treatment.
Patient Consensus: Patients emphasize that frequent screening in China helps catch cancer earlier than in Western countries. Many survivors stress the importance of verifying that a surgeon performs at least 20 gastrectomies annually for the best outcomes.
Laparoscopic and robotic gastrectomy are widely available in China for treating stomach cancer. These minimally invasive techniques are safe alternatives to open surgery. Both approaches offer faster recovery times. Surgeons use the Da Vinci Robotic System for high precision and 3D visualization.
Bookimed Expert Insight: While robotic surgery takes longer to set up, it is the superior choice for patients with complex cases or high BMI. Fuda Cancer Hospital in Guangzhou treats over 30,000 international patients and maintains JCI-accredited safety standards. Their specialists, like Dr. Leng Yin, often prioritize these minimally invasive methods to reduce trauma in advanced cases.
Patient Consensus: Patients find that the smaller incisions lead to much less pain after surgery. They often feel more comfortable and mobile just a few days after the procedure.
Stomach cancer treatment in China typically requires between 4 weeks and 6 months depending on the stage. Early-stage endoscopic procedures take only 1 to 2 days. Complex surgical pathways usually involve 2 weeks of hospitalization followed by 4 weeks of local recovery before flying.
Bookimed Expert Insight: Patients should note that Chinese clinical protocols, like those at Fuda Cancer Hospital, often favor longer inpatient stays than Western facilities. While a gastrectomy might have a 5-day hospital stay in the US, Chinese specialists often require 14 to 21 days. This approach focuses on intensive monitoring for post-operative leaks and immediate nutritional stabilization before discharge to a hotel.
Patient Consensus: Patients emphasize building in a 2-week buffer for discharge delays or minor recovery hurdles like delayed gastric emptying. Many recommend arranging follow-up chemotherapy with a local oncologist at home to avoid staying in-country for several months.
Guangzhou, Beijing, and Shanghai are the primary Chinese hubs for international patients seeking experienced stomach cancer care. These cities host JCI-accredited facilities specializing in advanced therapies. Specialized centers utilize cryosurgery, NanoKnife, and robotic-assisted resections for complex and late-stage gastric oncology cases.
Bookimed Expert Insight: While Beijing and Shanghai are prestigious, Guangzhou offers a unique balance of high volume and lower costs. Our data indicates that Sun Yat-sen University Cancer Center provides treatments approximately 30% to 50% more affordably than Beijing facilities. Furthermore, clinics like Fuda Cancer Hospital offer specialized interventions such as cryosurgery for late-stage cases. These are often unavailable at standard international hubs.
Patient Consensus: Patients note that public hospitals with dedicated international departments provide the best surgical volume. Many recommend hiring private translators in Shanghai and Beijing to navigate the complex hospital systems efficiently.
Post-operative dietary support for stomach cancer in China follows structured Enhanced Recovery After Surgery (ERAS) protocols. International patients receive personalized plans. These plans transition from full liquids to regular meals over 6 months. Multidisciplinary teams, including clinical dietitians, monitor nutritional intake and hydration status to ensure safe recovery.
Bookimed Expert Insight: JCI-accredited clinics like Fuda Cancer Hospital demonstrate a commitment to international safety standards. With over 30,000 international patients treated, these centers adapt traditional Chinese recovery foods. For example, dietitians may remove MSG from menus to better suit Western tastes. They also provide printed English guides to manage recovery after discharge.
Patient Consensus: Patients note that rice porridge and protein shakes are recovery staples. Many recommend using translation apps for dietitian visits and bringing electrolyte packets for easier hydration during the liquid phase.
Most international patients require a medical visa for stomach cancer treatment in China. JCI-accredited facilities provide essential invitation letters required for S1, S2, or M visas. Citizens from over 50 countries may currently benefit from 30-day visa-free entry for medical purposes.
Bookimed Expert Insight: Fuda Cancer Hospital serves over 30,000 international patients and manages complex visa paperwork efficiently. Our data shows hospitals in Guangzhou often email invitation letters within 48 hours. This speed is vital for patients seeking time-sensitive therapies like NanoKnife or Cryosurgery. Choosing a hospital experienced in international logistics ensures your entry permit matches the required treatment duration.
Patient Consensus: Patients note that emailing a preliminary diagnosis and passport scan quickly secures the invitation letter. Many suggest traveling with a companion as hospitals often bundle family visa invitations together.
Stomach cancer treatment in China centres on precision surgery and multimodal therapies. Specialists perform minimally invasive gastrectomies, including laparoscopic and robotic-assisted procedures. They also use specialised radiosurgery like CyberKnife M6 and targeted immunotherapy to manage complex oncology cases.
Bookimed Expert Insight: Chinese oncology centres often specialise in advanced-stage cases that other regions may deem inoperable. Fuda Cancer Hospital, for example, uses cryosurgery and NanoKnife as alternatives to traditional chemotherapy. This focus on minimally invasive technology allows for treating patients from many countries who require non-traditional surgical paths.
Patient Consensus: Patients highlight that Chinese treatment plans are highly staged and multidisciplinary. These plans combine surgery with precisely timed chemotherapy. Many note the importance of clarifying whether the approach is curative or palliative before starting the journey.
Chinese hospitals maintain high technological standards for stomach cancer by using robotic surgery and precision radiotherapy. Major centres use the Da Vinci robotic system for precise gastrectomies and lymph node removal. Leading facilities also offer non-invasive CyberKnife M6 radiosurgery and specialised treatments like NanoKnife and cryosurgery.
Bookimed Expert Insight: Chinese oncology centres combine traditional surgery with niche technologies like NanoKnife and microwave hyperthermia. Fuda Cancer Hospital specialises in these minimally invasive alternatives for late-stage cases. This approach serves patients who may not be candidates for standard chemotherapy. This versatility is rare outside of specialised Asian oncology hubs.
Patient Consensus: Patients find that major city hospitals in China offer fast, efficient care. They suggest arranging language support beforehand. High surgical volumes in Guangzhou and Xiamen provide confidence in complex staging and staging work-up.
Integrated treatment in China uses Traditional Chinese Medicine (TCM) as a supportive therapy alongside surgery and chemotherapy. It aims to reduce side effects, boost immunity, and improve general wellbeing. Major oncology centres combine modern technology with herbal formulas to help patients manage nausea and fatigue.
Bookimed Expert Insight: A distinct pattern in China is the naming of major medical institutions. Facilities like the Jinshazhou Hospital of Guangzhou University of Chinese Medicine integrate university-level TCM research with radiation technology. Dr Zhang Yanjun at this centre uses the CyberKnife M6 system for precise, non-invasive treatment. This reflects a hybrid model where TCM specialists and oncologists work in the same clinical environment.
Patient Consensus: Patients in China view TCM as a pragmatic tool for comfort and recovery rather than a standalone cure. They often use acupuncture or herbal teas to regain energy after surgery. However, they emphasise staying on standard oncology tracks.
China is a major hub for stomach cancer innovation. It offers therapies like Claudin 18.2 targeting and chemo-immunotherapy. Fuda Cancer Hospital provides minimally invasive options like NanoKnife and cryosurgery. Clinical trials in the region now account for 67% of global gastric cancer research.
Bookimed Expert Insight: Many think of China only for traditional medicine. However, the focus in Guangzhou is actually on local destruction. Fuda Cancer Hospital specialises in combining cryosurgery with vascular intervention. This approach serves over 30,000 international patients. It is a viable alternative for Australians seeking options beyond standard systemic chemo.
Stomach cancer treatment in China stays vary from 4 weeks to 6 months. This depends on the cancer stage. Surgeries like gastrectomy involve a 14-day hospital stay and 4 weeks of recovery. Diagnostics and non-invasive treatments often finish within 5 to 15 days.
Bookimed Expert Insight: Chinese protocols often favour longer hospital stays. However, facilities like Fuda Cancer Hospital specialise in minimally invasive alternatives. Using NanoKnife or vascular intervention can significantly reduce recovery time compared to traditional surgery.
International patients manage communication through dedicated service teams and telehealth tools. Major centres like Fuda Cancer Hospital coordinate care for over 30,000 international patients. Services include JCI-accredited standards, medical visa support, and video consultations before travel. Bilingual staff help manage PET/CT scans and treatment plans.
Bookimed Expert Insight: Chinese oncology centres often use mobile messaging apps for real-time coordination. Patients find this more effective than email for quick clinic transfers or medication queries. For complex cases involving CyberKnife or NanoKnife, these links maintain a continuous connection.
Patient Consensus: Patients recommend requesting all medication labels and aftercare instructions in writing. Bringing a companion helps confirm verbal instructions and provides support during busy hospital visits.
International patients choose China for stomach cancer treatment to access specialist surgeons with high clinical volumes. Facilities like Fuda Cancer Hospital offer minimally invasive NanoKnife therapy and robotic surgery. JCI-accredited centres provide international safety standards. They also offer faster oncology appointments than many private systems.
Bookimed Expert Insight: Many countries offer basic gastrectomies, but Chinese oncology centres specialise in NanoKnife and cryosurgery. Fuda Cancer Hospital has served over 30,000 international patients. It focuses on these minimally invasive options. This suggests a significant capability in treating patients who cannot have standard surgery.
Patient Consensus: Patients often choose China to avoid long wait times for scans and surgery. They value the affordability compared to private care. They also value the deep experience urban specialists have with complex stomach cases.